Gomes C, Trolin G, Henning M, Persson B
Clin Exp Hypertens (1978). 1980 Feb;2(2):273-96. doi: 10.3109/10641968009046424.
Intravenous (i.v.) injections of yohimbine, phentolamine, prazosine and phenoxybenzamine lowered blood pressure and increased heart rate in conscious rats. Intracerebroventricular (i.c.v.) injections of yohimbine and phentolamine increased blood pressure and heart rate; this was antogonized by pretreatment with clonidine. Phenoxybenzamine and prozosine had no effect or gave hypotension and tachycardia on i.c.v. injection. Pentobarbitone anaesthesia partly antagonized the cardiovascular effects of all alpha-adrenoceptor antagonist. Synthesis and utilization of central noradrenaline was increased by i.v. or i.c.v. yohimbine; anaesthesia partly antagonized this effect. In peripheral tissues others have found that yohimbine, tolazoline, piperoxan and phentolamine are potent blockers of the presynaptic alpha-adrenoceptors while phenoxybenzamine and prazosine act preferentially on postsynaptic alpha-adrenoceptors. The differentiated cardiovascular response to i.c.v. injection of these blockers may reflect their different affinity to central pre- and postsynaptic alpha-adrenoceptors.
静脉注射育亨宾、酚妥拉明、哌唑嗪和酚苄明可降低清醒大鼠的血压并增加心率。脑室内注射育亨宾和酚妥拉明可升高血压和心率;可乐定预处理可拮抗此作用。酚苄明和哌唑嗪脑室内注射无作用或引起低血压和心动过速。戊巴比妥麻醉部分拮抗了所有α-肾上腺素能拮抗剂的心血管效应。静脉或脑室内注射育亨宾可增加中枢去甲肾上腺素的合成和利用;麻醉部分拮抗此效应。在周围组织中,其他人发现育亨宾、妥拉唑啉、哌罗克生和酚妥拉明是突触前α-肾上腺素能受体的强效阻滞剂,而酚苄明和哌唑嗪则优先作用于突触后α-肾上腺素能受体。这些阻滞剂脑室内注射后不同的心血管反应可能反映了它们对中枢突触前和突触后α-肾上腺素能受体的不同亲和力。